Evaluation of the effect of Oak powder for the treatment of leishmaniasis.

Evaluation of the effect of herbal medicine prepared from Oak in human phase in patients with cutaneous leishmaniasis.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20201226049841N1

Enrollment

Registered

2021-01-26

Start date

2021-02-03

Completion date

Unknown

Last updated

2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Leishmaniasis. Leishmaniasis

Interventions

Intervention 1: Intervention group: cases under treatment with Oak ointment. Ingredients: Oak ointment, Density of 8g in 100 dosage of use. Consumption: Once a day with refreshing bondage. Number of u

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with active leishmaniasis ulcers on a part of their body. Patients with less than 4 months of leishmaniasis develops on their skin.

Exclusion criteria

Exclusion criteria: Patients with inactive leishmaniasis on their skin. Any drug allergy recognition by medical practitioner.

Design outcomes

Primary

Measure	Time frame
Wounds larger than = 3 cm. Timepoint: Before treatments begin and 8 weeks after it. Method of measurement: Direct blood smear and PCR test.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactVahid Sepehr

Sima Teb Clinic

info@simateb.com+98 51 3845 9666

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026